Therapeutic Asset Ratings
744 results matching 1 filter
128,541 assets · 8,669 sponsors · 3,127 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
chronic myeloid leukemia
City of Hope Medical Center
P2
B
(58)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
hematopoietic and lymphoid system neoplasm
City of Hope Medical Center
P2
B
(58)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
myeloproliferative neoplasm
City of Hope Medical Center
P2
B
(58)
Pvx-410
triple-negative breast carcinoma
OncoPep, Inc.
P2
B
(58)
9-valent human papillomavirus recombinant vaccine
human papillomavirus-related squamous cell carcinoma
Shanghai Bovax Biotechnology Co., Ltd.
P3
B
(57)
Bacillus Calmette-Guerin
dementia
Steven E Arnold, MD
P2
B
(57)
Dpx-Survivac
relapsed/refractory diffuse large B-cell lymphoma
ImmunoVaccine Technologies, Inc. (IMV Inc.)
P2
B
(57)
Grt-R902
colorectal neoplasm
Gritstone bio, Inc.
P2/3
B
(57)
Afluria
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Fluarix
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Flucelvax
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Flulaval
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Heplisav-B
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
pcv20
lymphoma
M.D. Anderson Cancer Center
P4
B
(56)
Pfizer-Covid-19 Vaccine
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Ppsv23
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Prevnar 13
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Prevnar 20
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Recombinant respiratory syncytial virus pre-fusion F protein antigen
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Shingrix
lymphoma
National Heart, Lung, and Blood Institute (NHLBI)
P4
B
(56)
Enavermotide
Alzheimer disease
Samsung Pharmaceutical Co., Ltd.
P3
B
(56)
Dpx-Survivac
fallopian tube cancer
University Health Network, Toronto
P2
B
(56)
Multi-Peptide Cmv-Modified Vaccinia Ankara Vaccine
acute lymphoblastic leukemia
City of Hope Medical Center
P2
B
(56)
Tetanus Toxoid
Glioblastoma
Charlotte Lemech
P2
B
(56)
Aadvac1
Alzheimer Disease
Paul S. Aisen
P2
CCC
(55)
Showing 101 to 125 of 744 assets
Previous
Page 5 of 30
Next
